AFMC Enhances TRAIL-Induced Apoptosis in Lung Cancer Cells
Author Information
Author(s): Xie Zhao-Hui, Quan Mei-Fang, Liu Fei, Cao Jian-Guo, Zhang Jian-Song
Primary Institution: Changsha Health Vocational College, Changsha, Hunan Province, China
Hypothesis
Does 5-allyl-7-gen-difluoromethoxychrysin (AFMC) enhance TRAIL-induced apoptosis in human lung carcinoma A549 cells?
Conclusion
AFMC synergistically enhances TRAIL-mediated apoptosis in NSCLC cells through up-regulating DR5 expression.
Supporting Evidence
- AFMC sensitized A549 cells to TRAIL-induced apoptosis.
- Co-treatment with AFMC and TRAIL activated caspases involved in apoptosis.
- AFMC increased the expression of death receptor 5 (DR5) in A549 cells.
- AFMC did not sensitize normal human embryo lung WI-38 cells to TRAIL-induced apoptosis.
Takeaway
AFMC helps a cancer treatment called TRAIL work better in lung cancer cells, making them die more easily.
Methodology
The study used colorimetry, flow cytometry, ELISA, and Western blot to assess cytotoxicity and apoptosis in A549 cells.
Limitations
The study primarily focused on A549 cells and did not explore the effects in vivo or in other cancer types extensively.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website